Moreover, we postulate that the MEK/ERK-FAM83A feed-forward loop may be a novel therapeutic target in pancreatic cancer cells, including those that remain dependent on mutant RAS, as well as those that are independent of mutant RAS. Here, SACK1A is linked to familial pancreatic carcinoma.